Valvular & structural heart disease

Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry

EuroInterventionPublished Retrospective registry study

Authors' conclusion

In small aortic annuli, implantation of SAV and SEV was associated with a more favourable forward haemodynamic profile than after IAV and BEV implantation, respectively. More than mild PVL was more common after SEV than BEV implantation.

Study context

Population
Severe AS with small annuli (annular perimeter <72 mm or area <400 mm²) treated with transfemoral TAVI, 2011–2020
Participants
1,378 participants
Exposure
SEV vs balloon-expandable valves (BEV) and SAV vs intra-annular valves (IAV) transcatheter aortic valves
  • SEVn = 1,092
  • BEVn = 286reference
  • SAVn = 920
  • IAVn = 458reference
Outcome
Predischarge mean aortic gradient and incidence of severe PPM
Follow-up
Predischarge
Methodological detailsinternational, multicentre, 16 high-volume centres, inverse probability of treatment weighting (IPTW)
  • International
  • Multicentre
  • 16 high-volume centres
  • Inverse probability of treatment weighting (IPTW)

Main finding

As reported in the abstract

Predischarge mean aortic gradient; severe PPM

Predischarge mean aortic gradient; severe PPM SEV 8.0 ± 4.1 · BEV 13.6 ± 4.7 · SAV 7.8 ± 3.9 · IAV 12.0 ± 5.1

Severe PPM

P = 0.007

  • SAV vs IAV: P < 0.001 — mean aortic gradient
  • SEV vs BEV: P < 0.001 — mean aortic gradient
  • BEV vs SEV: P = 0.041 — severe prosthesis-patient mismatch (PPM)

Observational data: associations, not effects.

Secondary outcomes

OutcomeSEVBEVP value
More than mild PVLSEV vs BEV11.6%2.6%P < 0.001

Original publication

Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry. EuroIntervention. Published 19 June 2023. doi:10.4244/eij-d-22-00843

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.